Katelijn Decochez

1.1k total citations
32 papers, 762 citations indexed

About

Katelijn Decochez is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Katelijn Decochez has authored 32 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 25 papers in Endocrinology, Diabetes and Metabolism and 23 papers in Surgery. Recurrent topics in Katelijn Decochez's work include Diabetes and associated disorders (26 papers), Diabetes Management and Research (23 papers) and Pancreatic function and diabetes (20 papers). Katelijn Decochez is often cited by papers focused on Diabetes and associated disorders (26 papers), Diabetes Management and Research (23 papers) and Pancreatic function and diabetes (20 papers). Katelijn Decochez collaborates with scholars based in Belgium, United States and Netherlands. Katelijn Decochez's co-authors include Ilse Weets, Frans Gorus, Daniël Pipeleers, Chantal Mathieu, Bart Keymeulen, Evy Vandemeulebroucke, Frederic Winnock, R. Rottiers, Ivo H. De Leeuw and Christophe De Block and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetologia.

In The Last Decade

Katelijn Decochez

30 papers receiving 738 citations

Peers

Countries citing papers authored by Katelijn Decochez

Since Specialization

Citations

This map shows the geographic impact of Katelijn Decochez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katelijn Decochez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katelijn Decochez more than expected).

Fields of papers citing papers by Katelijn Decochez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katelijn Decochez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katelijn Decochez. The network helps show where Katelijn Decochez may publish in the future.

Co-authorship network of co-authors of Katelijn Decochez

This figure shows the co-authorship network connecting the top 25 collaborators of Katelijn Decochez. A scholar is included among the top collaborators of Katelijn Decochez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katelijn Decochez. Katelijn Decochez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes 2015 ·Diabetologia ·(unknown), (unknown), (unknown), Eric V. Balti, Katelijn Decochez, Ilse Weets, Evy Vandemeulebroucke, Ursule Van de Velde, (unknown), (unknown), Christophe De Block, Johannes Ruige, Pieter Gillard, Bart Keymeulen, Daniël Pipeleers, Frans Gorus	16
2	Wat na zwangerschapsdiabetes? 2015 ·(unknown), F. Muylle, Katrien Benhalima, Katelijn Decochez, Roland Devlieger, Chantal Mathieu, Ann Verhaegen, Johan Wens	1
3	In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A24 and HLA-B18, but not HLA-B39, are predictors of impending diabetes with distinct HLA-DQ interactions 2013 ·Diabetologia* ·(unknown), (unknown), Bart Van Der Auwera, Ilse Weets, Paul Van Crombrugge, Laurent Crenier, (unknown), (unknown), Katelijn Decochez, Evy Vandemeulebroucke, Pieter Gillard, Bart Keymeulen, Christiaan Van Schravendijk, Janet M. Wenzlau, John C. Hutton, Daniël Pipeleers, Frans Gorus	13
4	Seroconversion to persistent islet autoantibody-positivity can occur at all ages, is best predicted by glutamate decarboxylase antibodies and is strongly associated with progression to diabetes 2011 ·Ghent University Academic Bibliography (Ghent University) ·(unknown), Ilse Vermeulen, Ilse Weets, (unknown), Katrijn Verhaeghen, Katelijn Decochez, Johannes Ruige, Kristina Casteels, Daniël Pipeleers, (unknown)	1
5	Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients 2009 ·Diabetologia ·(unknown), Evy Vandemeulebroucke, Bart Keymeulen, Katelijn Decochez, Ilse Weets, Christophe De Block, Françoise Féry, Ursule Van de Velde, Ilse Vermeulen, Pieter De Pauw, Chantal Mathieu, Daniël Pipeleers, Frans Gorus	20
6	Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2β) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials 2009 ·Diabetologia ·(unknown), (unknown), (unknown), Brice Nouthé, (unknown), Patrick Goubert, Ilse Vermeulen, (unknown), Katelijn Decochez, Ilse Weets, Bart Keymeulen, Vito Lampasona, Janet M. Wenzlau, John C. Hutton, Daniël Pipeleers, Frans Gorus	72
7	Insulin treatment in IA-2A-positive relatives of type 1 diabetic patients 2009 ·Diabetes & Metabolism ·Evy Vandemeulebroucke, Frans Gorus, Katelijn Decochez, Ilse Weets, Bart Keymeulen, Christophe De Block, (unknown), Daniël Pipeleers, Chantal Mathieu	31
8	Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetes 2007 ·Clinical & Experimental Immunology ·(unknown), (unknown), (unknown), Ilse Weets, L. Kaufman, Lissa Pipeleers, (unknown), Katelijn Decochez, Robert Hilbrands, (unknown), Bart Keymeulen, Chantal Mathieu, L. Van Gaal, Daniël Pipeleers, Frans Gorus	8
9	Adiponectin levels do not predict clinical onset of type 1 diabetes in antibody-positive relatives 2007 ·Diabetologia ·(unknown), (unknown), Christiaan Van Schravendijk, Dieter De Smet, Katelijn Decochez, Evy Vandemeulebroucke, M. Giri, Bart Keymeulen, Chantal Mathieu, L. Van Gaal, Pieter De Pauw, Ilse Weets, Daniël Pipeleers, Frans Gorus, (unknown)	6
10	A Dual PPAR ??/?? Agonist Increases Adiponectin and Improves Plasma Lipid Profiles in Healthy Subjects 2006 ·Drugs in R&D ·Katelijn Decochez, (unknown), Jutta Miller, Marina De Smet, (unknown), (unknown), Kerry Riffel, (unknown), Haiyuan Zhu, (unknown), Wesley Tanaka, Amy O. Johnson‐Levonas, Michael J. Davies, Keith Gottesdiener, Bart Keymeulen, John A. Wagner	16
11	Therapy with the hsp60 peptide DiaPep277^™ in C‐peptide positive type 1 diabetes patients 2006 ·Diabetes/Metabolism Research and Reviews ·Volkert A.L. Huurman, Katelijn Decochez, Chantal Mathieu, Irun R. Cohen, Bart O. Roep	62
12	Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes 2005 ·Diabetologia ·(unknown), (unknown), Pieter De Pauw, P N Jørgensen, Christiaan Van Schravendijk, (unknown), Katelijn Decochez, Evy Vandemeulebroucke, Ilse Weets, Ruifeng Mao, Daniël Pipeleers, Frans Gorus	64
13	Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes 2005 ·Diabetologia ·(unknown), Katelijn Decochez, (unknown), Bart Van Der Auwera, Ilse Weets, Evy Vandemeulebroucke, Ivo H. De Leeuw, Bart Keymeulen, Chantal Mathieu, R. Rottiers, Daniël Pipeleers, Frans Gorus	37
14	HLA-DQ restricted progression to clinical onset in antibody-positive first degree relatives of type 1 diabetic patients 2002 ·Diabetologia ·(unknown), Katelijn Decochez, (unknown), (unknown), Ilse Weets, I. De Leeuw, Bart Keymeulen, Chantal Mathieu, R. Rottiers, Daniël Pipeleers	1
15	The Presence of Thyrogastric Antibodies in First Degree Relatives of Type 1 Diabetic Patients Is Associated with Age and Proband Antibody Status 2001 ·The Journal of Clinical Endocrinology & Metabolism ·Christophe De Block, Ivo H. De Leeuw, Katelijn Decochez, Frederic Winnock, (unknown), (unknown), M. De Martin, Frans Gorus	22
16	Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index 2001 ·Diabetologia ·Ilse Weets, (unknown), Bart Van Der Auwera, Frans Schuit, M. V. L. Du Caju, Katelijn Decochez, Ivo H. De Leeuw, Bart Keymeulen, Chantal Mathieu, R. Rottiers, Harry Dorchy, Erik Quartier, Frans Gorus, (unknown)	46
17	Autoantibodies to a 38-kDa Glycosylated Islet Cell Membrane–Associated Antigen in (Pre)type 1 Diabetes 2001 ·Diabetes Care ·Frederic Winnock, Michael R. Christie, Manou R. Batstra, Henk‐Jan Aanstoot, Ilse Weets, Katelijn Decochez, (unknown), (unknown), Frans Gorus, (unknown)	15
18	High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. 2000 ·Diabetes Care ·Katelijn Decochez, (unknown), Jean-Luc Coolens, L. Van Gaal, G. Krzentowski, Frederic Winnock, Ellen Anckaert, Ilse Weets, Daniël Pipeleers, Frans Gorus	95
19	Le diabete de type 1: Une maladie auto-immune heterogene, predictible, evitable, guerissable? 1998 ·Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) ·Frans Gorus, Harry Dorchy, Bart Keymeulen, Christina Vandewalle, Katelijn Decochez, Ilse Weets, Frederic Winnock	1
20	Manifestations inaugurales du diabète de type 1 chez l'enfant, l'adolescent et l'adulte de moins de 40 ans 1998 ·Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) ·Harry Dorchy, Frans Gorus, Christina Vandewalle, Ilse Weets, Katelijn Decochez, K. Ver Elst, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact